1
Gout-Zwart, Judith J., de Jong, Lisa A., Saptenno, Lisanne, Postma, Maarten J
Veröffentlicht in: Gout-Zwart , J J , de Jong , L A , Saptenno , L & Postma , M J 2020 , ' Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands ' , PharmacoEconomics - open , vol. 4 , no. 2 , pp. 321-330 . https://doi.org/10.1007/s41669-019-00179-6;
2020
Veröffentlicht in: Gout-Zwart , J J , de Jong , L A , Saptenno , L & Postma , M J 2020 , ' Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands ' , PharmacoEconomics - open , vol. 4 , no. 2 , pp. 321-330 . https://doi.org/10.1007/s41669-019-00179-6;
2020
2
de Jong, Lisa Aniek, Gout-Zwart, Judith J, van den Bosch, Marina, Koops, Mike, Postma, Maarten J
Veröffentlicht in: de Jong , L A , Gout-Zwart , J J , van den Bosch , M , Koops , M & Postma , M J 2019 , ' Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands : a real-world data based cost-effectiveness analysis ' , Journal of Medical Economics , vol. 22 , no. 4 , pp. 306-318 . https://doi.org/10.1080/13696998.2018.1563404;
2019
Veröffentlicht in: de Jong , L A , Gout-Zwart , J J , van den Bosch , M , Koops , M & Postma , M J 2019 , ' Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands : a real-world data based cost-effectiveness analysis ' , Journal of Medical Economics , vol. 22 , no. 4 , pp. 306-318 . https://doi.org/10.1080/13696998.2018.1563404;
2019
3
Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands:A systematic review
van Schoonhoven, Alexander V, Gout-Zwart, Judith J, de Vries, Marijke J S, van Asselt, Antoinette D I, Dvortsin, Evgeni, Vemer, Pepijn, van Boven, Job F M, Postma, Maarten J
Veröffentlicht in: van Schoonhoven , A V , Gout-Zwart , J J , de Vries , M J S , van Asselt , A D I , Dvortsin , E , Vemer , P , van Boven , J F M & Postma , M J 2019 , ' Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands : A systematic review ' , PLoS ONE , vol. 14 , no. 9 , e0221856 . https://doi.org/10.1371/journal.pone.0221856;
2019
Veröffentlicht in: van Schoonhoven , A V , Gout-Zwart , J J , de Vries , M J S , van Asselt , A D I , Dvortsin , E , Vemer , P , van Boven , J F M & Postma , M J 2019 , ' Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands : A systematic review ' , PLoS ONE , vol. 14 , no. 9 , e0221856 . https://doi.org/10.1371/journal.pone.0221856;
2019